Înapoi la știri

Contestatie in cazul Damen Shipyards Mangalia SA la Tribunalul Constanta

24 Mar 2025
1 minut min
Simona Stan

Contestatie in cazul Damen Shipyards Mangalia SA la Tribunalul Constanta

Agentia Nationala de Administrare Fiscala a formulat o noua contestatie, conform ziarulamprenta.ro, în contradictoriu cu CITR SPRL. Contestatia se refera la raportul 877 din 4 martie 2025, care a fost publicat in Buletinul Procedurilor de Insolventa 5053, datat 11 martie 2025.

Dosarul pentru aceasta contestatie a fost inregistrat vineri, 21 martie 2025, la Sectia a II-a Civila a Tribunalului Constanta. Cazul are indicativul 3753/118/2024/a47, reprezentând astfel cea de-a 47-a contestatie inregistrata in legatura cu insolventa Damen Shipyards Mangalia SA.

Primul termen pentru solutionarea contestatiei va fi stabilit ulterior. Judecatorii de la Tribunal vor decide asupra contestatiei Agentiei Nationale de Administrare Fiscala, iar decizia lor va putea fi atacata la Curtea de Apel Constanta.

Legea 190 din 2018, articolul 7, stipuleaza ca activitatea jurnalistica are unele exemptii de la prevederile Regulamentului GDPR, atata timp cat se pastreaza un echilibru intre libertatea de exprimare si protectia datelor personale. Informatiile prezentate in acest articol sunt considerate de interes public si provin din surse publice deschise.

Citeste si: Vesti noi despre Damen Shipyards Mangalia SA: Sunt contestate raportul de activitate al administratorului judiciar si raportul cauzelor insolventei.

Alte postari din Economie
Economie

Lime begins life as a public company after years of uncertainty - TechCrunch

Micromobility company Lime has raised $167 million in its IPO, ending an almost decade-long run as a private company that saw wild valuation swings as it navigated multiple major hype cycles and a global pandemic. The nine-year-old scooter and bike company, which is backed by Uber, sold 6.68 million shares at $25 each, at the mid-point of its $24 to $26 price range.

Economie

Anthropic releases Claude Science, a product aimed at researchers, the pharma industry - statnews.com

Biotech Anthropic releases Claude Science, a product aimed at researchers, the pharma industry The AI giant is seeking to fundamentally upend the life sciences Manage alerts for this article Email this article Share this article Anthropic CEO Dario Amodei, left, with scientist Lotte Bjerre Knudsen and STAT’s Matthew Herper at an event to discuss Claude Science in San Francisco.Anthropic By Matthew Herper and Brittany Trang Matthew Herper covers medical innovation — both its promise and its perils. Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work?

Acasa Recente Radio Județe